An estimated 30%-50% of the general population are affected by insomnia, and 10% have chronic insomnia.
Insomnia is a symptom, not a stand-alone diagnosis or a disease. By definition, insomnia is “difficulty initiating or maintaining sleep or both” and it may be due to inadequate quality or quantity of sleep. Insomnia is not defined by a specific number of hours of sleep that one gets, since individuals vary widely in their sleep needs and practices. Although most of us know what insomnia is and how we feel and perform after one or more sleepless nights, few seek medical advice. Many people remain unaware of the behavioral and medical options available to treat insomnia.
Insomnia may be caused by a host of different reasons. These causes may be divided into situational factors, medical or psychiatric conditions, or primary sleep problems. Insomnia could also be classified by the duration of the symptoms into transient, short-term, or chronic. Transient insomnia generally last less than seven days; short-term insomnia usually lasts for about one to three weeks, and chronic insomnia lasts for more than three weeks.
Artemis Institute for Clinical Research is conducting a clinical trial of an investigational medication for the treatment of insomnia. Qualified persons that participate in this research study may receive monetary compensation for time and travel, study-related medical evaluations, psychological assessments and investigational study drug at no cost.
If you would like to participate in this clinical study, please complete our optional self-assessment questionnaire below or call (858) 278-3647 for more information.